Clinical impact of direct oral anticoagulant measuring in a real-life setting
Only sparse information exists on the use of direct oral anticoagulant (DOAC) testing and the impact on clinical management. Here, we evaluated the clinical impact of DOAC measurements in a real-life clinical setting. Moreover, number of tests performed in relation to number of DOAC-treated patients...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Winther-Larsen, Anne [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2019 |
|---|
| Umfang: |
6 |
|---|
| Übergeordnetes Werk: |
Enthalten in: DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer - 2012, vascular obstruction, hemorrhage and hemostasis, Amsterdam [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:175 ; year:2019 ; pages:40-45 ; extent:6 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.thromres.2019.01.016 |
|---|
| Katalog-ID: |
ELV04583136X |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV04583136X | ||
| 003 | DE-627 | ||
| 005 | 20230624120437.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 191021s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.thromres.2019.01.016 |2 doi | |
| 028 | 5 | 2 | |a GBV00000000000524.pica |
| 035 | |a (DE-627)ELV04583136X | ||
| 035 | |a (ELSEVIER)S0049-3848(19)30024-6 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q VZ |
| 082 | 0 | 4 | |a 610 |q VZ |
| 084 | |a 44.40 |2 bkl | ||
| 100 | 1 | |a Winther-Larsen, Anne |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Clinical impact of direct oral anticoagulant measuring in a real-life setting |
| 264 | 1 | |c 2019 | |
| 300 | |a 6 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a Only sparse information exists on the use of direct oral anticoagulant (DOAC) testing and the impact on clinical management. Here, we evaluated the clinical impact of DOAC measurements in a real-life clinical setting. Moreover, number of tests performed in relation to number of DOAC-treated patients was evaluated. | ||
| 700 | 1 | |a Hvas, Anne-Mette |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier Science |t DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer |d 2012 |d vascular obstruction, hemorrhage and hemostasis |g Amsterdam [u.a.] |w (DE-627)ELV011105356 |
| 773 | 1 | 8 | |g volume:175 |g year:2019 |g pages:40-45 |g extent:6 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.thromres.2019.01.016 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OPC-PHA | ||
| 912 | |a GBV_ILN_24 | ||
| 912 | |a GBV_ILN_40 | ||
| 936 | b | k | |a 44.40 |j Pharmazie |j Pharmazeutika |q VZ |
| 951 | |a AR | ||
| 952 | |d 175 |j 2019 |h 40-45 |g 6 | ||
| author_variant |
a w l awl |
|---|---|
| matchkey_str |
wintherlarsenannehvasannemette:2019----:lnclmatfietrlnioglnmauig |
| hierarchy_sort_str |
2019 |
| bklnumber |
44.40 |
| publishDate |
2019 |
| allfields |
10.1016/j.thromres.2019.01.016 doi GBV00000000000524.pica (DE-627)ELV04583136X (ELSEVIER)S0049-3848(19)30024-6 DE-627 ger DE-627 rakwb eng 610 VZ 610 VZ 44.40 bkl Winther-Larsen, Anne verfasserin aut Clinical impact of direct oral anticoagulant measuring in a real-life setting 2019 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Only sparse information exists on the use of direct oral anticoagulant (DOAC) testing and the impact on clinical management. Here, we evaluated the clinical impact of DOAC measurements in a real-life clinical setting. Moreover, number of tests performed in relation to number of DOAC-treated patients was evaluated. Hvas, Anne-Mette oth Enthalten in Elsevier Science DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer 2012 vascular obstruction, hemorrhage and hemostasis Amsterdam [u.a.] (DE-627)ELV011105356 volume:175 year:2019 pages:40-45 extent:6 https://doi.org/10.1016/j.thromres.2019.01.016 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA SSG-OPC-PHA GBV_ILN_24 GBV_ILN_40 44.40 Pharmazie Pharmazeutika VZ AR 175 2019 40-45 6 |
| spelling |
10.1016/j.thromres.2019.01.016 doi GBV00000000000524.pica (DE-627)ELV04583136X (ELSEVIER)S0049-3848(19)30024-6 DE-627 ger DE-627 rakwb eng 610 VZ 610 VZ 44.40 bkl Winther-Larsen, Anne verfasserin aut Clinical impact of direct oral anticoagulant measuring in a real-life setting 2019 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Only sparse information exists on the use of direct oral anticoagulant (DOAC) testing and the impact on clinical management. Here, we evaluated the clinical impact of DOAC measurements in a real-life clinical setting. Moreover, number of tests performed in relation to number of DOAC-treated patients was evaluated. Hvas, Anne-Mette oth Enthalten in Elsevier Science DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer 2012 vascular obstruction, hemorrhage and hemostasis Amsterdam [u.a.] (DE-627)ELV011105356 volume:175 year:2019 pages:40-45 extent:6 https://doi.org/10.1016/j.thromres.2019.01.016 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA SSG-OPC-PHA GBV_ILN_24 GBV_ILN_40 44.40 Pharmazie Pharmazeutika VZ AR 175 2019 40-45 6 |
| allfields_unstemmed |
10.1016/j.thromres.2019.01.016 doi GBV00000000000524.pica (DE-627)ELV04583136X (ELSEVIER)S0049-3848(19)30024-6 DE-627 ger DE-627 rakwb eng 610 VZ 610 VZ 44.40 bkl Winther-Larsen, Anne verfasserin aut Clinical impact of direct oral anticoagulant measuring in a real-life setting 2019 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Only sparse information exists on the use of direct oral anticoagulant (DOAC) testing and the impact on clinical management. Here, we evaluated the clinical impact of DOAC measurements in a real-life clinical setting. Moreover, number of tests performed in relation to number of DOAC-treated patients was evaluated. Hvas, Anne-Mette oth Enthalten in Elsevier Science DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer 2012 vascular obstruction, hemorrhage and hemostasis Amsterdam [u.a.] (DE-627)ELV011105356 volume:175 year:2019 pages:40-45 extent:6 https://doi.org/10.1016/j.thromres.2019.01.016 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA SSG-OPC-PHA GBV_ILN_24 GBV_ILN_40 44.40 Pharmazie Pharmazeutika VZ AR 175 2019 40-45 6 |
| allfieldsGer |
10.1016/j.thromres.2019.01.016 doi GBV00000000000524.pica (DE-627)ELV04583136X (ELSEVIER)S0049-3848(19)30024-6 DE-627 ger DE-627 rakwb eng 610 VZ 610 VZ 44.40 bkl Winther-Larsen, Anne verfasserin aut Clinical impact of direct oral anticoagulant measuring in a real-life setting 2019 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Only sparse information exists on the use of direct oral anticoagulant (DOAC) testing and the impact on clinical management. Here, we evaluated the clinical impact of DOAC measurements in a real-life clinical setting. Moreover, number of tests performed in relation to number of DOAC-treated patients was evaluated. Hvas, Anne-Mette oth Enthalten in Elsevier Science DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer 2012 vascular obstruction, hemorrhage and hemostasis Amsterdam [u.a.] (DE-627)ELV011105356 volume:175 year:2019 pages:40-45 extent:6 https://doi.org/10.1016/j.thromres.2019.01.016 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA SSG-OPC-PHA GBV_ILN_24 GBV_ILN_40 44.40 Pharmazie Pharmazeutika VZ AR 175 2019 40-45 6 |
| allfieldsSound |
10.1016/j.thromres.2019.01.016 doi GBV00000000000524.pica (DE-627)ELV04583136X (ELSEVIER)S0049-3848(19)30024-6 DE-627 ger DE-627 rakwb eng 610 VZ 610 VZ 44.40 bkl Winther-Larsen, Anne verfasserin aut Clinical impact of direct oral anticoagulant measuring in a real-life setting 2019 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Only sparse information exists on the use of direct oral anticoagulant (DOAC) testing and the impact on clinical management. Here, we evaluated the clinical impact of DOAC measurements in a real-life clinical setting. Moreover, number of tests performed in relation to number of DOAC-treated patients was evaluated. Hvas, Anne-Mette oth Enthalten in Elsevier Science DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer 2012 vascular obstruction, hemorrhage and hemostasis Amsterdam [u.a.] (DE-627)ELV011105356 volume:175 year:2019 pages:40-45 extent:6 https://doi.org/10.1016/j.thromres.2019.01.016 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA SSG-OPC-PHA GBV_ILN_24 GBV_ILN_40 44.40 Pharmazie Pharmazeutika VZ AR 175 2019 40-45 6 |
| language |
English |
| source |
Enthalten in DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer Amsterdam [u.a.] volume:175 year:2019 pages:40-45 extent:6 |
| sourceStr |
Enthalten in DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer Amsterdam [u.a.] volume:175 year:2019 pages:40-45 extent:6 |
| format_phy_str_mv |
Article |
| bklname |
Pharmazie Pharmazeutika |
| institution |
findex.gbv.de |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer |
| authorswithroles_txt_mv |
Winther-Larsen, Anne @@aut@@ Hvas, Anne-Mette @@oth@@ |
| publishDateDaySort_date |
2019-01-01T00:00:00Z |
| hierarchy_top_id |
ELV011105356 |
| dewey-sort |
3610 |
| id |
ELV04583136X |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV04583136X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624120437.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">191021s2019 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.thromres.2019.01.016</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBV00000000000524.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV04583136X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0049-3848(19)30024-6</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.40</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Winther-Larsen, Anne</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Clinical impact of direct oral anticoagulant measuring in a real-life setting</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2019</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">6</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Only sparse information exists on the use of direct oral anticoagulant (DOAC) testing and the impact on clinical management. Here, we evaluated the clinical impact of DOAC measurements in a real-life clinical setting. Moreover, number of tests performed in relation to number of DOAC-treated patients was evaluated.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hvas, Anne-Mette</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="t">DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer</subfield><subfield code="d">2012</subfield><subfield code="d">vascular obstruction, hemorrhage and hemostasis</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV011105356</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:175</subfield><subfield code="g">year:2019</subfield><subfield code="g">pages:40-45</subfield><subfield code="g">extent:6</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.thromres.2019.01.016</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.40</subfield><subfield code="j">Pharmazie</subfield><subfield code="j">Pharmazeutika</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">175</subfield><subfield code="j">2019</subfield><subfield code="h">40-45</subfield><subfield code="g">6</subfield></datafield></record></collection>
|
| author |
Winther-Larsen, Anne |
| spellingShingle |
Winther-Larsen, Anne ddc 610 bkl 44.40 Clinical impact of direct oral anticoagulant measuring in a real-life setting |
| authorStr |
Winther-Larsen, Anne |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV011105356 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 VZ 44.40 bkl Clinical impact of direct oral anticoagulant measuring in a real-life setting |
| topic |
ddc 610 bkl 44.40 |
| topic_unstemmed |
ddc 610 bkl 44.40 |
| topic_browse |
ddc 610 bkl 44.40 |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
a m h amh |
| hierarchy_parent_title |
DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer |
| hierarchy_parent_id |
ELV011105356 |
| dewey-tens |
610 - Medicine & health |
| hierarchy_top_title |
DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV011105356 |
| title |
Clinical impact of direct oral anticoagulant measuring in a real-life setting |
| ctrlnum |
(DE-627)ELV04583136X (ELSEVIER)S0049-3848(19)30024-6 |
| title_full |
Clinical impact of direct oral anticoagulant measuring in a real-life setting |
| author_sort |
Winther-Larsen, Anne |
| journal |
DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer |
| journalStr |
DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology |
| recordtype |
marc |
| publishDateSort |
2019 |
| contenttype_str_mv |
zzz |
| container_start_page |
40 |
| author_browse |
Winther-Larsen, Anne |
| container_volume |
175 |
| physical |
6 |
| class |
610 VZ 44.40 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Winther-Larsen, Anne |
| doi_str_mv |
10.1016/j.thromres.2019.01.016 |
| dewey-full |
610 |
| title_sort |
clinical impact of direct oral anticoagulant measuring in a real-life setting |
| title_auth |
Clinical impact of direct oral anticoagulant measuring in a real-life setting |
| abstract |
Only sparse information exists on the use of direct oral anticoagulant (DOAC) testing and the impact on clinical management. Here, we evaluated the clinical impact of DOAC measurements in a real-life clinical setting. Moreover, number of tests performed in relation to number of DOAC-treated patients was evaluated. |
| abstractGer |
Only sparse information exists on the use of direct oral anticoagulant (DOAC) testing and the impact on clinical management. Here, we evaluated the clinical impact of DOAC measurements in a real-life clinical setting. Moreover, number of tests performed in relation to number of DOAC-treated patients was evaluated. |
| abstract_unstemmed |
Only sparse information exists on the use of direct oral anticoagulant (DOAC) testing and the impact on clinical management. Here, we evaluated the clinical impact of DOAC measurements in a real-life clinical setting. Moreover, number of tests performed in relation to number of DOAC-treated patients was evaluated. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA SSG-OPC-PHA GBV_ILN_24 GBV_ILN_40 |
| title_short |
Clinical impact of direct oral anticoagulant measuring in a real-life setting |
| url |
https://doi.org/10.1016/j.thromres.2019.01.016 |
| remote_bool |
true |
| author2 |
Hvas, Anne-Mette |
| author2Str |
Hvas, Anne-Mette |
| ppnlink |
ELV011105356 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth |
| doi_str |
10.1016/j.thromres.2019.01.016 |
| up_date |
2024-07-06T18:36:22.883Z |
| _version_ |
1803855837667524608 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV04583136X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624120437.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">191021s2019 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.thromres.2019.01.016</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBV00000000000524.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV04583136X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0049-3848(19)30024-6</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.40</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Winther-Larsen, Anne</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Clinical impact of direct oral anticoagulant measuring in a real-life setting</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2019</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">6</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Only sparse information exists on the use of direct oral anticoagulant (DOAC) testing and the impact on clinical management. Here, we evaluated the clinical impact of DOAC measurements in a real-life clinical setting. Moreover, number of tests performed in relation to number of DOAC-treated patients was evaluated.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hvas, Anne-Mette</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="t">DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer</subfield><subfield code="d">2012</subfield><subfield code="d">vascular obstruction, hemorrhage and hemostasis</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV011105356</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:175</subfield><subfield code="g">year:2019</subfield><subfield code="g">pages:40-45</subfield><subfield code="g">extent:6</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.thromres.2019.01.016</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.40</subfield><subfield code="j">Pharmazie</subfield><subfield code="j">Pharmazeutika</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">175</subfield><subfield code="j">2019</subfield><subfield code="h">40-45</subfield><subfield code="g">6</subfield></datafield></record></collection>
|
| score |
7.399315 |